Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2025-06-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
董事会提名委员会关于第六届董事会董事候选人任职资格的审查意见
Board/Management Information Classification · 100% confidence The document is a formal opinion from the Board Nomination Committee regarding the qualifications of candidates for the company's sixth board of directors. It references compliance with company law, stock exchange regulations, and internal company rules. The content focuses on the nomination and qualification review of board candidates, including independent directors, and does not contain financial data or results. This fits the category of Board/Management Information (MANG), which covers announcements related to changes or nominations in the company's board of directors or senior management.
2025-06-30 Chinese
内部审计制度
Audit Report / Information Classification · 95% confidence The document is titled '内部审计制度' which translates to 'Internal Audit System' or 'Internal Audit Policy' of 特一药业集团股份有限公司. It details the internal audit framework, responsibilities, procedures, and governance within the company. It references laws and regulations related to auditing and internal control, describes the internal audit institution's duties, reporting to the audit committee and board, and the handling of audit findings. There are no financial statements, quarterly or annual financial results, or earnings data presented. The document is a policy or procedural document related to internal audit and control, not an audit report or annual report itself. It is not a certification or a short announcement but a detailed internal governance document. Given the content, it fits best under the category of Audit Report / Information (AR), which includes applied accounting principles and internal audit information, excluding full annual reports. The document is not a full audit report with financial statements but an internal audit system document, which is consistent with AR category. Confidence is high due to the detailed internal audit focus and regulatory references. FY 2025
2025-06-30 Chinese
独立董事专门会议制度
Governance Information Classification · 95% confidence The document is a detailed internal governance policy regarding the independent directors' special meeting system of a company. It outlines the roles, responsibilities, meeting procedures, voting rules, and confidentiality obligations of independent directors. It references relevant laws and company bylaws but does not contain financial data, audit results, or shareholder voting outcomes. It is a governance-related document focused on board structure and practices rather than a report, announcement, or financial filing. Therefore, it fits best under Governance Information (CGR). The document length is 2166 characters, which is consistent with a policy document rather than a full report or announcement.
2025-06-30 Chinese
关于第五届董事会第三十三次会议决议的公告
Board/Management Information Classification · 100% confidence The document is an announcement of the resolutions passed at the 33rd meeting of the 5th Board of Directors of 特一药业集团股份有限公司. It details the meeting date, attendance, agenda items, voting results, and plans for submitting certain matters to the shareholders' meeting. The content focuses on board decisions such as changes in registered capital, amendments to company bylaws, board member nominations, and scheduling a shareholders' meeting. There are no financial statements, earnings data, or detailed management analysis. The document is a formal disclosure of board meeting resolutions and related governance matters, not a full report or financial filing. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2025-06-30 Chinese
关于第五届监事会第二十九次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of a resolution passed at a supervisory board meeting regarding a proposal to change the company's registered capital and amend the articles of association. It references that detailed content is disclosed elsewhere on a regulatory website. The document is short (554 characters) and serves as a formal notice of the meeting resolution, not the full report or detailed financial data. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories like capital change announcement (SHA) because it does not itself announce the capital change but the meeting resolution about it, and it is not a full report or financial statement.
2025-06-30 Chinese
会计师事务所选聘制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled 'Accounting Firm Selection System' for a company, outlining procedures, responsibilities, and requirements for selecting and managing accounting firms for audit purposes. It does not contain financial statements, audit reports, or results of audits. It is a governance-related document describing internal rules and processes related to audit firm selection and oversight. Therefore, it fits best under Governance Information (CGR) rather than an audit report or annual report. The document length is 4436 characters, which is substantial and contains detailed governance content, not a brief announcement or certification. Hence, the classification is CGR with high confidence.
2025-06-30 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.